Jade Biosciences Inc (JBIO)

07:16 AM

Jade Biosciences doses first patient in IgAN phase 2 trial - Investing.com

07:16 AM

07:01 AM

Kidney disease in young adults: Jade starts Phase 2 JADE101 trial - Stock Titan

07:01 AM

07:00 AM

Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy - GlobeNewswire

07:00 AM

May 25, 2026

Jade Biosciences (JBIO) Falters in Mid-Session Trading: Support Levels in FocusIPO Entry Watch - Newser

May 25, 2026

May 24, 2026

Jade Biosciences Inc. (JBIO) Q1 2026 Earnings: EPS Miss Amid Continued Pre‑Revenue PhaseHot Momentum Watchlist - Newser

May 24, 2026

May 23, 2026

Jade Biosciences Inc. (JBIO) Q1 2026 Earnings: Clinical‑stage Biotech Misses Consensus as Cash Burn AcceleratesLive Trade Sharing - Newser

May 23, 2026

May 22, 2026

Jade Biosciences Inc. (JBIO) Holds Steady as Price Consolidates Near Key ResistanceCatalyst Driven Stocks - Newser

May 22, 2026

May 21, 2026

Jade Biosciences (JBIO) price target increased by 16.48% to 26.14 - MSN

May 21, 2026

May 18, 2026

[EFFECT] Jade Biosciences, Inc. SEC Filing - Stock Titan

May 18, 2026

May 15, 2026

Jade Biosciences IncProspectus filed for resale of up to 39,542,339 shares by selling stockholdersSEC filing - marketscreener.com

May 15, 2026

May 15, 2026

Jade Biosciences (JBIO) Declines -4.19% Amid Market Weakness 2026-05-15Expert Breakout Alerts - newser.com

May 15, 2026

May 15, 2026

Jade Biosciences (JBIO) Q1 2026 Disappoints — EPS $-0.57 Below $-0.49 ViewsForward Guidance - newser.com

May 15, 2026

May 14, 2026

Jade Biosciences(JBIO) Stock Options Chain | Quotes & News - Moomoo

May 14, 2026

May 14, 2026

Jade Biosciences (JBIO) Q1 2026 Earnings Miss by Significant: Key TakeawaysHealthcare Earnings Report - Newser

May 14, 2026

May 12, 2026

H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $45 - Moomoo

May 12, 2026

May 11, 2026

Jade Biosciences Price Target Raised to $34.00/Share From $24.00 by Wedbush - Moomoo

May 11, 2026

May 11, 2026

Jade Biosciences (NASDAQ:JBIO) Given New $34.00 Price Target at Wedbush - MarketBeat

May 11, 2026

May 11, 2026

Guggenheim Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $32 - Moomoo

May 11, 2026

May 09, 2026

Jade Biosciences (NASDAQ:JBIO) Cut to "Sell" at Wall Street Zen - MarketBeat

May 09, 2026

May 08, 2026

Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach - TipRanks

May 08, 2026

May 08, 2026

Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target - TipRanks

May 08, 2026

May 08, 2026

TD Cowen Maintains Jade Biosciences(JBIO.US) With Buy Rating - Moomoo

May 08, 2026

May 08, 2026

Stifel Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $40 - Moomoo

May 08, 2026

May 07, 2026

Jade Biosciences : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

May 07, 2026

May 07, 2026

Why Jade Biosciences (JBIO) looks attractive at current levels (Edges Lower) 2026-05-07Investment Community Signals - Newser

May 07, 2026

May 07, 2026

Jade Biosciences Inc may offer and sell up to $600 million of securitiesSEC filing - marketscreener.com

May 07, 2026

May 07, 2026

[S-3] Jade Biosciences, Inc. Shelf Registration Statement - Stock Titan

May 07, 2026

May 07, 2026

Jade Biosciences (NASDAQ: JBIO) posts $40.4M Q1 loss, ATM up to $200M - Stock Titan

May 07, 2026

May 07, 2026

Jade Biosciences (JBIO) ramps R&D with $40.4M loss and $311M cash - Stock Titan

May 07, 2026

May 07, 2026

Jade Biosciences (NASDAQ: JBIO) details Q1 2026 loss and cash - Stock Titan

May 07, 2026

May 07, 2026

2 small-cap stocks with big potential to buy under $30 - MSN

May 07, 2026

May 07, 2026

BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million - TradingView

May 07, 2026

May 07, 2026

Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update - ChartMill

May 07, 2026

May 04, 2026

JBIO SEC FilingsJade Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 04, 2026

May 02, 2026

Jade Biosciences Reshapes Clinical Leadership As Valuation Debate Persists - Sahm

May 02, 2026

May 01, 2026

2 Small-Cap Stocks With Big Potential to Buy Under $30 - Barchart.com

May 01, 2026

Apr 29, 2026

Jade Biosciences (NASDAQ:JBIO) Stock Price Down 9.6%Here's What Happened - MarketBeat

Apr 29, 2026

Apr 29, 2026

What is HC Wainwright's Forecast for JBIO FY2030 Earnings? - MarketBeat

Apr 29, 2026

Apr 28, 2026

Jade Biosciences (NASDAQ: JBIO) outlines 2026 director votes, auditor and jury waiver - Stock Titan

Apr 28, 2026

Apr 28, 2026

Jade Biosciences (NASDAQ:JBIO) Sets New 1-Year HighHere's What Happened - MarketBeat

Apr 28, 2026

Apr 28, 2026

FY2028 Earnings Forecast for JBIO Issued By HC Wainwright - MarketBeat

Apr 28, 2026

Apr 28, 2026

Jade Biosciences stock hits 52-week high at 27.44 USD By Investing.com - Investing.com South Africa

Apr 28, 2026

Apr 27, 2026

Jade Biosciences (JBIO) price target increased by 10.24% to 28.82 - MSN

Apr 27, 2026

Apr 27, 2026

BlackRock (NYSE: JBIO) reports 2.3M JADE stake, 4.7% disclosed - Stock Titan

Apr 27, 2026

Apr 27, 2026

Jade Biosciences stock hits 52-week high at 27.44 USD - Investing.com

Apr 27, 2026

Apr 27, 2026

Jade Biosciences stock price target raised to $45 by H.C. Wainwright - Investing.com Canada

Apr 27, 2026

Apr 27, 2026

H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $45 - Moomoo

Apr 27, 2026

Apr 27, 2026

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Apr 27, 2026

Apr 26, 2026

Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update - MarketBeat

Apr 26, 2026